QIAGEN Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Launch of Companion Diagnostics Genetics Investing
XELJANZ (tofacitinib citrate) Receives Marketing Authorization in the European Union for Moderately to Severely Active Ulcerative Colitis Pharmaceutical Investing
Cellectar and Orano Med Announce Collaboration to Develop New Phospholipid Drug Conjugate Biotech Investing
Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke Biotech Investing
ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation Biotech Investing
Innovate Biopharmaceuticals Enters into a Collaboration on Larazotide’s Effect on Improving the Microbiome of Children with EED with the University of Virginia School of Medicine Biotech Investing
PreveCeutical Provides Update on Second Phase of Scorpion Venom-Derived Peptide Program Biotech Investing
Lexicon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides a Business Update Pharmaceutical Investing
Immune Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation in the European Union for Bertilimumab for the Treatment of Bullous Pemphigoid Pharmaceutical Investing
